companies making glp-1 drugs 3 at the Forefront of the Pill Wars GLP-1 Receptor Agonist Companies and
Description
Angarita Dvila L, et al
So the drug is there, but its full effect isnt
10.1016/s0140-6736(23)01185-6
More GLP-1 was needed to have the same biological effect, meaning they were resistant to GLP-1. Seeking confirmation The results were so surprising, Gloyns team spent the next several years confirming them
Consider lowering the dose of the insulin secretagogue to reduce the risk of hypoglycemia
These effects explain why gastrointestinal side effects are among the most commonly reported adverse reactions to GLP-1 therapy
